compare glp 1 drugs Pharmacology Consult: GLP-1 receptor agonists for weight loss management

Not all medical weight loss is created equal. Online pharmacies make it easy to get a GLP 1 prescription shipped to your door. But easy isn't the same as effective or safe. A Orforglipron, an oral small molecule GLP 1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN 2): a phase 3, double blind, randomised, multicentre, placebo controlled trial The Lancet New guidelines for GLP 1 weight loss drugs released People with pre existing depression or anxiety were less likely to have mental health worsening while taking a GLP 1 medication, observational Swedish data suggested. https: www.medpagetoday.com psychiatry generalpsychiatry 120515 FDA Approved: Orforglipron (Foundayo) Oral GLP 1 Drug FDA approved for chronic weight management Indicated for obesity and overweight with comorbidities Oral, once daily GLP 1 receptor agonist First non peptide GLP 1s & Beyond: Understanding Incretin Mimetic Opportunities Blue Matter Consulting